Stemtech Appoints Dr. Lizette Leos, MD, to Chief Scientific Officer

Naples, FL – Stemtech Corporation (OTCQB:STEK), a global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Lizette Leos, MD, to the role of Chief Scientific Officer.

President & COO, John W. Meyer stated:

“Dr. Leos has been with Stemtech since 2017 and has significantly contributed to the science, creation and development, including education of our stemceuticals^™ all-natural, plant-based, non-GMO nutritional supplements designed to support the body’s own regenerative processes*.

“Promoting her to the role of Chief Scientific Officer recognizes both her longstanding impact and leadership in the development of new evidence-driven innovations. Her scientific knowledge of our products, ability to translate complex biology into practical education, and commitment to Stemtech’s non-chemical approaches to cellular health have been instrumental to Stemtech’s growth, with focus on anti-aging* and longevity. We are very excited about the future under her expanded scientific leadership.”

Mr. Meyer continued,

“As Chief Scientific Officer, Dr. Leos will lead Stemtech Corporation’s global scientific validation, education and regulatory alignment for Stemtech’s recently announced joint ventures in Stemtech HealthSciences India Pvt Ltd and the GCC (Gulf Cooperation Council countries of the United Arab Emirates, Bahrain, Saudi Arabia, Qatar, Kuwait and Oman). In addition, Dr. Leos will also support Stemtech Asia (Hong Kong) for business in the Peoples Republic of China.”

Dr. Leos commented,

“It is an honor to step into the role of Chief Scientific Officer at a pivotal moment in Stemtech’s evolution. Stemtech has been a pioneer in demonstrating how all-natural, plant-based nutrition can activate and support the body’s own regenerative capacity* without reliance on synthetic or chemical interventions. My vision is to further strengthen our scientific governance, expand evidence-based education globally, and ensure that innovation, regulatory responsibility, and integrity remain at the core of everything we do as we advance the future of longevity and cellular health.”

Dr. Leos is a medical doctor based in Guadalajara, Mexico, and has worked with Stemtech since 2017. She holds a Master’s Degree in Aesthetic and Anti-Aging Medicine from the Instituto Mexicano de Medicina Antienvejecimiento y Estética (IMMAE) (2023), postgraduate training in Molecular Nutrition and Smart Food Design from Tecnológico de Monterrey, Campus Guadalajara (2018), and earned her Medical Degree from Universidad Guadalajara Lamar, with her professional title issued by the Universidad de Guadalajara (2007).

With over 10 years of experience in regenerative medicine, nutrigenomics, cellular health, and aesthetic medicine, Dr. Leos has served on the Stemtech Life Sciences Advisory Board, where she has designed global educational programs, scientific symposiums, and evidence-based clinical and educational protocols. She brings deep expertise in scientific and medical communication, clinical protocol development, and cross-functional collaboration across scientific, regulatory, and commercial teams. Fluent in English and Spanish, she contributes significant cross-cultural leadership to Stemtech’s international operations.

About Stemtech

Stemtech Corporation is a publicly traded wellness company specializing in stemceuticals^™ – all-natural, plant-based nutritional solutions designed to support the body’s natural regenerative processes*. Founded in 2018, following the acquisition of the operations from Stemtech International, Inc., (established in 2005), the company has a long history of innovation in stem cell nutrition and wellness science.

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.